The PVG is a machine learning for medical imaging research lab headed by Tal Arbel at McGill and Mila.
The Probabilistic Vision Group (PVG) excels in software development, particularly in the dynamic fields of computer vision, machine learning, and medical image analysis. PVG is dedicated to advancing probabilistic machine learning frameworks tailored for real-world applications in neurology and neurosurgery.
PVG's research is focused on developing advanced deep learning models for inference in medical image analysis, especially in the presence of pathological structures. Their innovative approaches include estimating uncertainties, knowledge distillation, enhancing interpretability, domain adaptation, and leveraging self-supervision. These efforts extend to multi-modal predictions, integrating clinical and imaging data to improve segmentation, detection, and probabilistic lesion count estimation, ultimately driving precision medicine based on patient brain images.
The Probabilistic Vision Group (PVG) is committed to continuous improvement and innovation in patient care, evident in their development of probabilistic graphical machine learning algorithms for Multiple Sclerosis (MS) lesion detection and segmentation. These algorithms are used in the clinical trial analysis of most new multiple sclerosis drugs worldwide. The PVG will soon complete its profile with more detailed information, supported by the company’s management.
We invite the manager of The Probabilistic Vision Group (PVG) to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and capabilities.
Other organizations in the same industry
This company is also known as